Empowering Ocular Health: Discover PharmAlliance International Labs Private Limited’s Polymyxin B Sulphate Range

Step into the realm of cutting-edge ocular care with PharmAlliance International Labs Private Limited’s revolutionary Polymyxin B Sulphate Range. Our dedication to advancing healthcare through innovative pharmaceutical solutions shines through in this breakthrough medication tailored to combat bacterial infections of the eye.

Pharmacokinetics:

Polymyxin B Sulphate, an esteemed member of the antibiotic polymyxin class, executes its bactericidal prowess by disrupting the structural integrity of bacterial cell membranes. Upon ocular administration (E. Drop), this potent antibiotic minimally infiltrates systemic circulation, instead preferring localized action to eradicate susceptible bacteria swiftly. Witness the rapid onset of action, with therapeutic concentrations swiftly attained in ocular tissues mere minutes post-application.

Pharmacodynamics:

Classified as a polypeptide antibiotic, Polymyxin B Sulphate demonstrates formidable efficacy against gram-negative bacteria, including the notorious Pseudomonas aeruginosa. By binding to the lipid constituents of bacterial cell membranes, it precipitates membrane destabilization, culminating in cytoplasmic leakage and eventual bacterial demise. This mechanism renders it an indispensable weapon against bacterial conjunctivitis and diverse ocular infections instigated by susceptible pathogens.

Drug Classification:

Polymyxin B Sulphate, a stalwart within the polypeptide antibiotic cadre, is hailed as a cornerstone in antimicrobial therapeutics. Its pivotal role in ophthalmology is underscored by its efficacy in combating bacterial eye infections, including conjunctivitis and keratitis.

Formulations:

Explore our meticulously formulated Polymyxin B Sulphate Range, available in the form of sterile ophthalmic solution, with each milliliter housing 10,000 units of the active ingredient.

Indications:

Indicated for the treatment of bacterial conjunctivitis, keratitis, and an array of ocular infections stemming from gram-negative organisms, Polymyxin B Sulphate emerges as a beacon of hope. Whether deployed as monotherapy or in synergy with complementary antimicrobial agents, its versatility ensures optimal therapeutic outcomes.

Usage:

Prior to each application, ensure thorough agitation of the bottle. Administer one to two drops of Polymyxin B Sulphate into the affected eye(s) every 3 to 4 hours, meticulously adhering to healthcare provider directives. Gently incline the head backward, delicately retract the lower eyelid, and instill the prescribed dosage, taking care to avert contact between the dropper tip and any surface.

Dosage:

Embrace the recommended dosage regimen, entailing the administration of one to two drops into the affected eye(s) every 3 to 4 hours. Your healthcare provider may tailor the dosage regimen to align with the severity of your infection and your individual treatment response. Exercise caution to avoid surpassing the prescribed dosage sans prior consultation.

Side Effects:

While generally well-tolerated, Polymyxin B Sulphate may occasionally evoke transient ocular irritation, a burning sensation, or stinging upon installation, accompanied by fleeting episodes of blurred vision. In rare instances, allergic reactions may manifest as itching, eyelid or conjunctival redness, or swelling. Promptly discontinue medication usage and seek medical counsel upon encountering any atypical symptoms or side effects.

Place your trust in PharmAlliance International Labs Private Limited’s Polymyxin B Sulphate Range to vanquish bacterial eye infections and restore ocular equilibrium. With an unwavering dedication to quality and patient satisfaction, we remain steadfast in our pursuit of delivering safe and reliable treatments tailored to cater to the diverse needs of our esteemed clientele.